The company's low P/S ratio and declining revenue indicate u...
The company's low P/S ratio and declining revenue indicate underperformance compared to the industry. If recent medium-term revenue trends persist, the share price is unlikely to see significant movement.
Revenues Working Against Shanxi Zhendong Pharmaceutical Co.,Ltd's (SZSE:300158) Share Price Following 26% Dive
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment